These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35687524)

  • 21. Rationalization of the Membrane Permeability Differences in a Series of Analogue Cyclic Decapeptides.
    Witek J; Wang S; Schroeder B; Lingwood R; Dounas A; Roth HJ; Fouché M; Blatter M; Lemke O; Keller B; Riniker S
    J Chem Inf Model; 2019 Jan; 59(1):294-308. PubMed ID: 30457855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging strategies to access peptide macrocycles from genetically encoded polypeptides.
    Smith JM; Frost JR; Fasan R
    J Org Chem; 2013 Apr; 78(8):3525-31. PubMed ID: 23517465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CREMP: Conformer-rotamer ensembles of macrocyclic peptides for machine learning.
    Grambow CA; Weir H; Cunningham CN; Biancalani T; Chuang KV
    Sci Data; 2024 Aug; 11(1):859. PubMed ID: 39122750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Illuminating the dark conformational space of macrocycles using dominant rotors.
    Diaz DB; Appavoo SD; Bogdanchikova AF; Lebedev Y; McTiernan TJ; Dos Passos Gomes G; Yudin AK
    Nat Chem; 2021 Mar; 13(3):218-225. PubMed ID: 33589789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Macrocyclic drugs and clinical candidates: what can medicinal chemists learn from their properties?
    Giordanetto F; Kihlberg J
    J Med Chem; 2014 Jan; 57(2):278-95. PubMed ID: 24044773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Solvatochromic reagents for multicomponent reactions and their utility in the development of cell-permeable macrocyclic peptide vectors.
    Rotstein BH; Mourtada R; Kelley SO; Yudin AK
    Chemistry; 2011 Oct; 17(44):12257-61. PubMed ID: 21932287
    [No Abstract]   [Full Text] [Related]  

  • 27. Drug-Like Properties in Macrocycles above MW 1000: Backbone Rigidity versus Side-Chain Lipophilicity.
    Furukawa A; Schwochert J; Pye CR; Asano D; Edmondson QD; Turmon AC; Klein VG; Ono S; Okada O; Lokey RS
    Angew Chem Int Ed Engl; 2020 Nov; 59(48):21571-21577. PubMed ID: 32789999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural and conformational determinants of macrocycle cell permeability.
    Over B; Matsson P; Tyrchan C; Artursson P; Doak BC; Foley MA; Hilgendorf C; Johnston SE; Lee MD; Lewis RJ; McCarren P; Muncipinto G; Norinder U; Perry MW; Duvall JR; Kihlberg J
    Nat Chem Biol; 2016 Dec; 12(12):1065-1074. PubMed ID: 27748751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell-permeable cyclic peptides from synthetic libraries inspired by natural products.
    Hewitt WM; Leung SS; Pye CR; Ponkey AR; Bednarek M; Jacobson MP; Lokey RS
    J Am Chem Soc; 2015 Jan; 137(2):715-21. PubMed ID: 25517352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting the Permeability of Macrocycles from Conformational Sampling - Limitations of Molecular Flexibility.
    Poongavanam V; Atilaw Y; Ye S; Wieske LHE; Erdelyi M; Ermondi G; Caron G; Kihlberg J
    J Pharm Sci; 2021 Jan; 110(1):301-313. PubMed ID: 33129836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nature Builds Macrocycles and Heterocycles into Its Antimicrobial Frameworks: Deciphering Biosynthetic Strategy.
    Walsh CT
    ACS Infect Dis; 2018 Sep; 4(9):1283-1299. PubMed ID: 29993235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of Functional Macrocyclic Peptides by Means of the RaPID System.
    Tsiamantas C; Otero-Ramirez ME; Suga H
    Methods Mol Biol; 2019; 2001():299-315. PubMed ID: 31134577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strategies for transitioning macrocyclic peptides to cell-permeable drug leads.
    Walport LJ; Obexer R; Suga H
    Curr Opin Biotechnol; 2017 Dec; 48():242-250. PubMed ID: 28783603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tackling the conformational sampling of larger flexible compounds and macrocycles in pharmacology and drug discovery.
    Chen IJ; Foloppe N
    Bioorg Med Chem; 2013 Dec; 21(24):7898-920. PubMed ID: 24184215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conformational Effects on the Passive Membrane Permeability of Synthetic Macrocycles.
    Rzepiela AA; Viarengo-Baker LA; Tatarskii V; Kombarov R; Whitty A
    J Med Chem; 2022 Aug; 65(15):10300-10317. PubMed ID: 35861996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solution Conformations Explain the Chameleonic Behaviour of Macrocyclic Drugs.
    Danelius E; Poongavanam V; Peintner S; Wieske LHE; Erdélyi M; Kihlberg J
    Chemistry; 2020 Apr; 26(23):5231-5244. PubMed ID: 32027758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improving the Cell Permeability of Polar Cyclic Peptides by Replacing Residues with Alkylated Amino Acids, Asparagines, and d-Amino Acids.
    Buckton LK; McAlpine SR
    Org Lett; 2018 Feb; 20(3):506-509. PubMed ID: 29364690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ribosomal Synthesis of Macrocyclic Peptides with β
    Adaligil E; Song A; Hallenbeck KK; Cunningham CN; Fairbrother WJ
    ACS Chem Biol; 2021 Jun; 16(6):1011-1018. PubMed ID: 34008946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Permeability prediction in the beyond-Rule-of 5 chemical space: Focus on cyclic hexapeptides.
    Digiesi V; de la Oliva Roque V; Vallaro M; Caron G; Ermondi G
    Eur J Pharm Biopharm; 2021 Aug; 165():259-270. PubMed ID: 34038796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cu(II) coordination chemistry of patellamide derivatives: possible biological functions of cyclic pseudopeptides.
    Comba P; Dovalil N; Gahan LR; Haberhauer G; Hanson GR; Noble CJ; Seibold B; Vadivelu P
    Chemistry; 2012 Feb; 18(9):2578-90. PubMed ID: 22266951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.